أرسل هذا في رسالة قصيرة: A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1)

  ______     ___      ______     ___     _    _   
 /_   _//   / _ \\   /_   _//   / _ \\  | \  / || 
 `-| |,-   | / \ ||  `-| |,-   / //\ \\ |  \/  || 
   | ||    | \_/ ||    | ||   |  ___  ||| .  . || 
   |_||     \___//     |_||   |_||  |_|||_|\/|_|| 
   `-`'     `---`      `-`'   `-`   `-` `-`  `-`